Biotech Series: Alto Neuroscience CEO Dr. Amit Etkin on the Next Chapter in Mental Health Treatment

from Inside the ICE House · host Intercontinental Exchange

The future of mental health is being transformed, moving beyond trial-and-error treatments to science-driven precision. Breakthroughs in neuroscience, AI, and precision medicine are mapping the brain’s unique biological signatures, creating pathways for personalized care. Alto Neuroscience is at the forefront, using brain biomarkers and AI to match patients with the right therapies—fast. Founded in 2019 by Dr. Amit Etkin, the company is rewriting the rules of mental health treatment. He goes Inside the ICE house to explain how Alto is turning guesswork into guided science and offering hope where it once felt out of reach.

Episode metadata supplied by the publisher feed · Published Sep 2, 2025

Embed this episode

Attribution link and audio player

Ready to play

Biotech Series: Alto Neuroscience CEO Dr. Amit Etkin on the Next Chapter in Mental Health Treatment

0:00 20:14

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Inside the ICE House?

This episode is 20 minutes long.

When was this Inside the ICE House episode published?

This episode was published on September 2, 2025.

Can I download this Inside the ICE House episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!